In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines-Reference-Cited by-同舟云学术

In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines

Published:2016-11 Issue: Volume:123 Page:128-140
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Borges Layla J.H.,Bull Érika S.,Fernandes Christiane,Horn Adolfo,Azeredo Nathalia F.,Resende Jackson A.L.C.,Freitas William R.,Carvalho Eulógio C.Q.,Lemos Luciana S.,Jerdy Hassan,Kanashiro Milton M.

Funder

CAPES

FAPERJ

CNPq

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference71 articles.

1. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study;Bray;Lancet Oncol.,2012

2. Copper(III) coordination compounds: classification and analysis of crystallographic and structural data;Melník;J. Coord. Chem.,2000

3. Advances in copper complexes as anticancer agents;Santini;Chem. Rev.,2014